Bay Area biotech boosts IPO targets by 38%, hopes to raise up to $254M
July 09, 2020 at 10:35 AM EDT
The South San Francisco company is one of five local IPOs waiting in the wings from the life science sector that has already produced six IPOs in the region that have brought returns of between 54% and 188% so far in 2020.